The nomogram based on BIRC5 mRNA expression is also expected to be a practical clinical tool for assessing BCR risk in PCa patients due to its good prediction efficiency and help urologists in clinical decision-making. The gene discussed is BCR; the disease is posterior cortical atrophy.